The largest database of trusted experimental protocols

Htr8 svneo

Manufactured by Merck Group
Sourced in United States

The HTR8/SVneo is a cell line derived from human first-trimester extravillous trophoblast. It is commonly used as an in vitro model for the study of trophoblast biology and placental development.

Automatically generated - may contain errors

3 protocols using htr8 svneo

1

Culturing Immortalized Human Trophoblast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human chorionic trophoblast cells (HTR8/SVneo) were obtained from Shanghai kanglang biotechnology co., LTD (China). The cells originated from human first trimester placenta and immortalized by transfection with a cDNA construct that encodes the simian virus 40 large T antigen (Graham et al., 1993). HTR8/SVneo cells were maintained in RPMI 1,640 solution (Sigma) supplemented with 10% fetal bovine serum (FBS). The medium was supplemented with 100 U/ml penicillin and 100 U/ml streptomycin (Sigma). HTR8/SVneo cells were seeded in 24‐well plates in humidified 5% CO2 at 37°C until reaching 70%–80% confluence.
+ Open protocol
+ Expand
2

Gestational Diabetes Mellitus Cell Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human trophoblast cells (HTR-8/SVneo) provided by Procell (Wuhan, China) were cultured in RPMI1640 medium containing 10% FBS at 37°C incubator mixed with 5% CO 2 . Cell model of GDM was constructed by treating HTR-8/SVneo cells with HG (30 mM; Sigma-Aldrich, St. Louis, MO, USA) for 24 h as previously described [16] [17] [18] . Cells in the control group were treated with normal glucose (5.5 mM).
+ Open protocol
+ Expand
3

Choriocarcinoma Trophoblast Cell Lines Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The choriocarcinoma trophoblast cell lines, BeWo, Jar, and Jeg‐3, were from American Type Culture Collection (ATCC). The non‐tumor trophoblast HTR‐8/SVneo was a gift from Prof. Charles Graham (Queen's University at Kingston, Canada). Human umbilical vein endothelial cells (HUVECs; originally from ATCC) and aortic endothelial cells (HAoECs; originally from PromoCell GmbH) were provided by Dr. Andriana Margariti and Prof. David Grieve, respectively (Queen's University Belfast, UK). BeWo cells were maintained in DMEM/F12 Gibco (Thermo Fisher) supplemented with 2 mmol/L L‐glutamate. Jar and HTR‐8/SVneo were cultured in RPMI 1640 (Sigma‐Aldrich), and Jeg‐3 was cultured in EMEM (ATCC). Both HUVECs and HAoECs were cultured in EGM‐2 (Lonza) with all vendor‐provided supplements in flasks or plates coated with 0.1% gelatin (Sigma‐Aldrich). All growth media contained 10% fetal calf serum. There was no mycoplasma contamination with the cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!